Checkpoint Therapeutics, Inc. (CKPT)
NASDAQ: CKPT · Real-Time Price · USD
3.750
+0.380 (11.28%)
At close: Dec 20, 2024, 4:00 PM
3.700
-0.050 (-1.33%)
After-hours: Dec 20, 2024, 7:59 PM EST
Checkpoint Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.05 | 0.1 | 0.19 | 0.27 | 1.07 | 1.71 | |
| Revenue Growth (YoY) | -72.51% | -46.35% | -28.36% | -74.93% | -37.41% | -51.28% | |
| Cost of Revenue | 27.64 | 43.57 | 49.83 | 48.45 | 16.35 | 19.33 | |
| Gross Profit | -27.6 | -43.46 | -49.63 | -48.19 | -15.28 | -17.62 | |
| Selling, General & Admin | 9.92 | 8.69 | 8.7 | 8.54 | 7.92 | 7.23 | |
| Operating Expenses | 9.92 | 8.69 | 8.7 | 8.54 | 7.92 | 7.23 | |
| Operating Income | -37.51 | -52.15 | -58.33 | -56.72 | -23.2 | -24.85 | |
| Interest & Investment Income | 0.01 | 0.08 | 0.16 | 0.05 | 0.12 | 0.14 | |
| Other Non Operating Income (Expenses) | -8.96 | 0.22 | -4.45 | - | - | - | |
| Pretax Income | -46.47 | -51.85 | -62.62 | -56.67 | -23.08 | -24.71 | |
| Net Income | -46.47 | -51.85 | -62.62 | -56.67 | -23.08 | -24.71 | |
| Net Income to Common | -46.47 | -51.85 | -62.62 | -56.67 | -23.08 | -24.71 | |
| Shares Outstanding (Basic) | 46 | 28 | 10 | 8 | 6 | 4 | |
| Shares Outstanding (Diluted) | 46 | 28 | 10 | 8 | 6 | 4 | |
| Shares Change (YoY) | 104.42% | 169.69% | 21.63% | 51.48% | 58.14% | 23.64% | |
| EPS (Basic) | -1.01 | -1.87 | -6.09 | -6.70 | -4.13 | -7.00 | |
| EPS (Diluted) | -1.01 | -1.87 | -6.09 | -6.70 | -4.13 | -7.00 | |
| Free Cash Flow | -30.76 | -47.59 | -57.55 | -26.31 | -16.55 | -21.37 | |
| Free Cash Flow Per Share | -0.67 | -1.72 | -5.60 | -3.11 | -2.96 | -6.05 | |
| Operating Margin | -79817.02% | -50629.13% | -30381.77% | -21165.30% | -2170.35% | -1454.92% | |
| Profit Margin | -98868.09% | -50336.89% | -32616.67% | -21145.52% | -2159.12% | -1446.96% | |
| Free Cash Flow Margin | -65440.43% | -46203.88% | -29976.04% | -9815.67% | -1548.27% | -1251.35% | |
| EBIT | -37.51 | -52.15 | -58.33 | -56.72 | -23.2 | -24.85 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.